From Medscape Dermatology

American Academy of Dermatology (AAD) 2018 Annual Meeting

February 16 - 20, 2018; San Diego, California

February 16 - 20, 2018 San Diego, California

AAD Aggressive Skin Cancer Rates Skyrocketing The incidence of Merkel cell carcinoma is increasing exponentially as the US population ages, a new national study shows.
Medscape Medical News, February 19, 2018
AAD Acne Can Be More Distressing Than Melanoma Inflammatory skin diseases cause more harm than skin cancers when years of disability are considered, according to the latest report from the Global Burden of Disease Study.
Medscape Medical News, February 18, 2018

AAD Oral Eczema Treatments Generate Excitement
Medscape Medical News, February 21, 2018
AAD Experimental Biologic Surpasses Ustekinumab for Psoriasis
Medscape Medical News, February 20, 2018
AAD Aggressive Skin Cancer Rates Skyrocketing
Medscape Medical News, February 19, 2018

AAD Acne Can Be More Distressing Than Melanoma
Medscape Medical News, February 18, 2018
AAD Immune Modulation in the Spotlight at AAD 2018
Medscape Medical News, February 12, 2018

Low Vitamin D Concerns Lead to Overtesting and Overtreatment Supplements are safe and cheap, while tests can be expensive and inconsistent, experts said. They also addressed controversies around how much vitamin D is necessary and its association with diseases.
Medscape Medical News, Mar 4, 2017
New Topical for Mild to Moderate Psoriasis in the Works It's been decades since a new topical option has been available for mild-to-moderate psoriasis, but a new agent shows promise in a phase 3 trial presented as a late-breaker at the AAD Annual Meeting.
Medscape Medical News, Mar 5, 2017
JAK Inhibitors Show Promise for Alopecia, Eczema, Vitiligo A researcher at the forefront shares promising results from small studies. Clinical trials are in progress and he predicts FDA approval for a JAK inhibitor for alopecia and eczema within 3 years.
Medscape Medical News, Mar 7, 2017

Medscape Dermatology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Medscape Board at the Podium

Previous Coverage